Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,030,000
+13,000 (1.28%)
At close: Sep 5, 2025
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 73.31 trillion as of September 5, 2025. Its market cap has increased by 10.99% in one year.
Market Cap
73.31T
Enterprise Value
73.08T
Revenue
5.03T
Ranking
n/a
PE Ratio
57.01
Stock Price
1,030,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 73.31T, an increase of 669.43%. That is a compound annual growth rate of 26.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 72.38T | 7.17% |
| Dec 30, 2024 | 67.54T | 24.87% |
| Dec 28, 2023 | 54.09T | -7.43% |
| Dec 29, 2022 | 58.43T | -2.20% |
| Dec 30, 2021 | 59.75T | 9.32% |
| Dec 30, 2020 | 54.65T | 90.76% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 37.78T |
| ALTEOGEN | 24.77T |
| Yuhan | 8,835.06B |
| SK Biopharmaceuticals | 8,379.52B |
| Peptron | 7,094.04B |
| PharmaResearch | 6,462.36B |
| LigaChem Biosciences | 5,488.57B |
| ABL Bio | 5,211.92B |